They don't want to be a part of an equity stake w/ Big Pharma
?
and Director of the Start-up and Spin-off Program from the Swiss Federal Institute of Technology in Lausanne (EPFL). During his tenure, more than 35 spin-offs were launched. In parallel, he served as expert for new ventures creation at the Swiss Federal Commission for Technology and Innovation (CTI) in Bern.